You are here: Industry Insights > NOD

News List

NICE nod for Blincyto pharmatimes
June 19, 2019
The National Institute for Health and Care Excellence (NICE) has announced the recommendation of Amgen’s Blincyto (blinatumomab) for treating acute lymphoblastic leukaemia (ALL). The indication is for patients in first complete remission with minimal resi
Samsung Bioepis gets nod for sale of biosimilar drug in Europe firstwordpharma
March 06, 2019
Samsung Bioepis has won European approval of a 420-mg dosage of Ontruzant, a biosimilar of Roche's Herceptin, The Korea Herald reported Tuesday.
Roche's Genentech to acquire inflammatory drug discovery firm Jecure pharmafile
November 30, 2018
Roche’s subsidiary Genentech has finalised a definitive agreement to acquire Jecure, a US-based biotech which focuses on the discovery of drugs to treat serious inflammatory conditions, in a bid to square up to rivals in the treatment of fatty liver disea
Roche's Genentech to acquire inflammatory drug discovery firm Jecure pharmafile
November 29, 2018
Roche’s subsidiary Genentech has finalised a definitive agreement to acquire Jecure, a US-based biotech which focuses on the discovery of drugs to treat serious inflammatory conditions...